22:24:28 EDT Mon 07 Oct 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:TH - THERATECHNOLOGIES INC. - http://www.theratech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TH - T  0.51.63·1.700.61.70+0.053.039.3581481.66  1.70  1.633.43  1.2716:00:00Sep 2615 min RT 2¢
TSX - T0.51.63·1.700.61.70+0.053.028.9421151.66  1.70  1.633.43  1.2716:00:0015 min
NEO ATS - U 1.64-0.01-0.62.3441.67  1.67  1.6414:53:2715 min
Chi-X - X 1.69+0.042.47.612201.68  1.69  1.6515:59:2915 min
CX2 - H 1.69+0.042.40.3021.67  1.69  1.6715:59:2915 min
CXD - D 1.650.052    Oct 0415 min
TriAct - M 1.650.1005    Sep 11-2015 min

Recent Trades - Last 10 of 148
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00T1.700.051001 Anonymous19 DesjardinsKQ
15:59:29H1.690.0420079 CIBC79 CIBCK
15:59:29X1.690.0410079 CIBC79 CIBCK
15:59:29T1.690.0430079 CIBC1 AnonymousK
15:59:29T1.690.0440079 CIBC80 National BankK
15:59:29X1.680.0380079 CIBC79 CIBCK
15:59:29X1.670.0210079 CIBC79 CIBCK
15:59:29T1.680.0310079 CIBC79 CIBCK
15:59:29T1.680.0350079 CIBC19 DesjardinsK
15:59:29T1.680.0320079 CIBC19 DesjardinsK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-09-26 09:54C:TH1.60News ReleaseTheratechnologies to release Q3 2024 results Oct. 10
2024-09-17 17:08C:TH1.88News ReleaseTheratechnologies sees Egrifta supply disruption risk
2024-07-10 08:53C:TH2.10SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-10 08:53C:TH2.10SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-10 08:47C:TH2.10SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-10 07:30C:TH2.10News ReleaseTheratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
2024-06-26 11:33C:TH1.78News ReleaseTheratechnologies to release Q2 2024 results July 10
2024-05-23 17:07C:TH1.71News ReleaseTheratechnologies' TH1902 phase 1 data show efficacy
2024-05-09 16:48C:TH1.71News ReleaseTheratechnologies holders elect 8 directors at meeting
2024-04-15 16:39C:TH1.80News ReleaseTheratechnologies mails proxy circular for May 9 AGM
2024-04-10 11:45C:TH2.09News ReleaseTheratechnologies loses $4.48-million (U.S.) in Q1
2024-04-10 07:54C:TH2.09SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-08 16:43C:TH1.93News ReleaseTheratechnologies presents preclinical data on SORT1+
2024-04-05 11:28C:TH2.06News ReleaseTheratechnologies appoints Tea as director
2024-04-03 11:00C:TH2.16News ReleaseTheratechnologies to release Q1 2024 results April 10
2024-03-22 10:56C:TH1.70News ReleaseTheratechnologies to cut preclinical cancer research
2024-03-21 20:06C:TH1.70News ReleaseTheratechnologies appoints Zwick as director
2024-03-21 10:52C:TH1.65News ReleaseTheratechnologies increases dose level in phase 1 trial